Literature DB >> 19524671

Brainstem Alzheimer's-like pathology in the triple transgenic mouse model of Alzheimer's disease.

Cassia R Overk1, Christy M Kelley, Elliott J Mufson.   

Abstract

The triple transgenic mouse (3xTgAD), harboring human APP(Swe), PS1(M146V) and Tau(P301L) genes, develops age-dependent forebrain intraneuronal Abeta and tau as well as extraneuronal plaques. We evaluated brainstem AD-like pathology using 6E10, AT8, and Alz50 antibodies and unbiased stereology in young and old 3xTgAD mice. Intraneuronal Abeta occurred in the tectum, periaqueductal gray, substantia nigra, red nucleus, tegmentum and mesencephalic V nucleus at all ages. Abeta-positive neuron numbers significantly decreased in the superior colliculus and substantia nigra while AT8-positive superior colliculus, red nucleus, principal sensory V, vestibular nuclei, and tegmental neurons significantly increased between 2 and 12 months. Alz50-positive neuron numbers increased only in the inferior colliculus between these ages. Dual labeling revealed a few Abeta- and tau-positive neurons. Plaques occurred only in the pons of female 3xTgAD mice starting at 9 months. 3xTgAD mice provide a platform to define in vivo mechanisms of Abeta and tau brainstem pathology.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19524671      PMCID: PMC3085918          DOI: 10.1016/j.nbd.2009.06.004

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  51 in total

1.  The selective vulnerability of brainstem nuclei to Alzheimer's disease.

Authors:  J Parvizi; G W Van Hoesen; A Damasio
Journal:  Ann Neurol       Date:  2001-01       Impact factor: 10.422

2.  Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein.

Authors:  J Lewis; E McGowan; J Rockwood; H Melrose; P Nacharaju; M Van Slegtenhorst; K Gwinn-Hardy; M Paul Murphy; M Baker; X Yu; K Duff; J Hardy; A Corral; W L Lin; S H Yen; D W Dickson; P Davies; M Hutton
Journal:  Nat Genet       Date:  2000-08       Impact factor: 38.330

3.  Time course of the development of Alzheimer-like pathology in the doubly transgenic PS1+APP mouse.

Authors:  Marcia N Gordon; Leigh A Holcomb; Paul T Jantzen; Giovanni DiCarlo; Donna Wilcock; Kristal W Boyett; Karen Connor; Jason Melachrino; James P O'Callaghan; Dave Morgan
Journal:  Exp Neurol       Date:  2002-02       Impact factor: 5.330

4.  Neuropathology of mice carrying mutant APP(swe) and/or PS1(M146L) transgenes: alterations in the p75(NTR) cholinergic basal forebrain septohippocampal pathway.

Authors:  S Jaffar; S E Counts; S Y Ma; E Dadko; M N Gordon; D Morgan; E J Mufson
Journal:  Exp Neurol       Date:  2001-08       Impact factor: 5.330

5.  Improved detection of substantia nigra pathology in Alzheimer's disease.

Authors:  Julie A Schneider; Julia L Bienias; David W Gilley; David E Kvarnberg; Elliott J Mufson; David A Bennett
Journal:  J Histochem Cytochem       Date:  2002-01       Impact factor: 2.479

6.  Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP.

Authors:  J Lewis; D W Dickson; W L Lin; L Chisholm; A Corral; G Jones; S H Yen; N Sahara; L Skipper; D Yager; C Eckman; J Hardy; M Hutton; E McGowan
Journal:  Science       Date:  2001-08-24       Impact factor: 47.728

7.  Tau filament formation in transgenic mice expressing P301L tau.

Authors:  J Götz; F Chen; R Barmettler; R M Nitsch
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

8.  Selective cell loss in Edinger-Westphal in asymptomatic elders and Alzheimer's patients.

Authors:  L F Scinto; M Frosch; C K Wu; K R Daffner; N Gedi; C Geula
Journal:  Neurobiol Aging       Date:  2001 Sep-Oct       Impact factor: 4.673

9.  Phases of A beta-deposition in the human brain and its relevance for the development of AD.

Authors:  Dietmar R Thal; Udo Rüb; Mario Orantes; Heiko Braak
Journal:  Neurology       Date:  2002-06-25       Impact factor: 9.910

10.  Intracellular Aß triggers neuron loss in the cholinergic system of the APP/PS1KI mouse model of Alzheimer's disease.

Authors:  Ditte Z Christensen; Thomas A Bayer; Oliver Wirths
Journal:  Neurobiol Aging       Date:  2008-09-03       Impact factor: 4.673

View more
  27 in total

1.  Age-related loss of noradrenergic neurons in the brains of triple transgenic mice.

Authors:  Kebreten F Manaye; Peter R Mouton; Guang Xu; Amy Drew; De-Liang Lei; Yukti Sharma; G William Rebeck; Scott Turner
Journal:  Age (Dordr)       Date:  2011-11-30

Review 2.  Turning on the Light Within: Subcortical Nuclei of the Isodentritic Core and their Role in Alzheimer's Disease Pathogenesis.

Authors:  Panos Theofilas; Sara Dunlop; Helmut Heinsen; Lea Tenenholz Grinberg
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

3.  Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice.

Authors:  Christy M Kelley; Brian E Powers; Ramon Velazquez; Jessica A Ash; Stephen D Ginsberg; Barbara J Strupp; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2014-04-15       Impact factor: 3.215

4.  Biochemical and morphological characterization of the AβPP/PS/tau triple transgenic mouse model and its relevance to sporadic Alzheimer's disease.

Authors:  Jesse M Hunter; William J Bowers; Chera L Maarouf; Michael A Mastrangelo; Ian D Daugs; Tyler A Kokjohn; Walter M Kalback; Dean C Luehrs; Jon Valla; Thomas G Beach; Alex E Roher
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

5.  A progressive dopaminergic phenotype associated with neurotoxic conversion of α-synuclein in BAC-transgenic rats.

Authors:  Silke Nuber; Florian Harmuth; Zacharias Kohl; Anthony Adame; Margaritha Trejo; Kai Schönig; Frank Zimmermann; Claudia Bauer; Nicolas Casadei; Christiane Giel; Carsten Calaminus; Bernd J Pichler; Poul H Jensen; Christian P Müller; Davide Amato; Johannes Kornhuber; Peter Teismann; Hodaka Yamakado; Ryosuke Takahashi; Juergen Winkler; Eliezer Masliah; Olaf Riess
Journal:  Brain       Date:  2013-02       Impact factor: 13.501

6.  A novel approach for long-term oral drug administration in animal research.

Authors:  Cassia R Overk; Jeffrey A Borgia; Elliott J Mufson
Journal:  J Neurosci Methods       Date:  2010-12-14       Impact factor: 2.390

7.  Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis.

Authors:  Kwang-Jin Oh; Sylvia E Perez; Sarita Lagalwar; Laurel Vana; Lester Binder; Elliott J Mufson
Journal:  Int J Alzheimers Dis       Date:  2010-07-15

8.  Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.

Authors:  Brian Spencer; Paula A Desplats; Cassia R Overk; Elvira Valera-Martin; Robert A Rissman; Chengbiao Wu; Michael Mante; Anthony Adame; Jazmin Florio; Edward Rockenstein; Eliezer Masliah
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

9.  Sex steroid levels and AD-like pathology in 3xTgAD mice.

Authors:  Cassia R Overk; Sylvia E Perez; Chunqi Ma; Matthew D Taves; Kiran K Soma; Elliott J Mufson
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

10.  Age-related changes in neuroactive steroid levels in 3xTg-AD mice.

Authors:  Donatella Caruso; Anna M Barron; Meghan A Brown; Federico Abbiati; Paloma Carrero; Christian J Pike; Luis M Garcia-Segura; Roberto C Melcangi
Journal:  Neurobiol Aging       Date:  2012-11-02       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.